About Baxter International Inc
- Industry: Health Care
- Exchange: NEW YORK STOCK EXCHANGE, INC.
- Country: US
- Website: https://www.baxter.com/
Frequently Asked Questions
What is the 52-week range for BAX?
The 52-week high is $30 and the 52-week low is $15.73.
What is the P/E ratio for BAX?
The P/E ratio data is currently unavailable.
What is the dividend yield for BAX?
The indicated annual dividend yield is 3.22%.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -16.60%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -9.27%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 1.60.
Analyst Recommendation Trends
Wall Street analyst consensus for BAX over the last few months:
Latest BAX News
3 of Wall Street’s Favorite Stocks with Warning Signs
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
What Investors Might Be Missing On Baxter International (BAX)
Baxter International (BAX) has drawn fresh attention after publishing its 2026 Connected Hospital Report, spotlighting how U.S. hospitals are using technology maturity benchmarks to pursue operational efficiency, workflow automation, and data integration priorities. Baxter International’s recent Connected Hospital Report lands after a mixed run in the stock, with the share price up 20.41% year to date and 8.25% over 90 days but down 10.14% over the past month. Total shareholder return sits at...
Baxter Releases Inaugural Connected Hospital Report
DEERFIELD, Ill., September 30, 2026--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the release of its 2026 Connected Hospital Report, offering new insights into how hospitals across the United States are leveraging technology investments to drive clinical and operational outcomes.
Global Remote Cardiac Monitoring Market Size, Share & Trends Analysis 2026-2036 Featuring Profiles of Medtronic, Abbott Labs, Boston Scientific, GE HealthCare Technologies, Philips, Baxter International (Hillrom) and Other Key Players
Growth is driven by rising cardiovascular disease, telehealth adoption, and advances in wearable ECG devices, implantable monitors, AI analytics, and cloud platforms. North America leads, while Asia-Pacific is expected to grow fastest.Dublin, Sept. 28, 2026 (GLOBE NEWSWIRE) -- "Remote Cardiac Monitoring Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)" has been added to ResearchAndMarkets.com's offering.The global Remote Cardiac Monitoring Mark
Here's Why You Should Retain Baxter Stock in Your Portfolio for Now
BAX's portfolio reset and growth in connected care and advanced surgery support prospects, but margins, Novum IQ and China pricing remain risks.
2 Volatile Stocks for Long-Term Investors and 1 Facing Challenges
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared.
These S&P500 stocks are moving in today's session
Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session.
Is Baxter Stock Underperforming the Nasdaq?
Baxter International has underperformed the Nasdaq over the past year, and analysts are cautious about the stock’s prospects.
Top 3 Health Care Stocks That May Rocket Higher In September
CVS, Steris and Baxter are oversold healthcare stocks with RSI readings near or below 30, potentially offering undervalued buying opportunities.
Microsoft Leads S&P 500 Stocks Going Nowhere
A year of stagnation is setting up an important test
Baxter International Inc. (BAX) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Baxter International Inc. (BAX) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 12:45 PM EDTCompany ParticipantsAndrew Hider - CEO,...
BAX Raises 2026 Outlook as Strong Q2 Growth Offsets Margin Pressure
Baxter raises its 2026 sales and earnings outlook after strong Q2 growth, though manufacturing costs, tariffs and pricing pressure margins.
Drug Reconstitution Systems Market Trends, Shares and Growth Opportunities Worldwide 2026-2035 Featuring Profiles of Baxter, ICU Medical, B. Braun, Vetter Pharma, Nipro, SCHOTT-KAISHA
Dublin, Sept. 07, 2026 (GLOBE NEWSWIRE) -- The "Drug Reconstitution Systems Market - Trends and Forecast Till 2035" has been added to ResearchAndMarkets.com's offering. The global drug reconstitution systems market is projected to increase from approximately USD 5.9 billion in 2026 to USD 10.8 billion by 2035, representing a compound annual growth rate (CAGR) of about 7.0% during the forecast period. Market expansion is being supported by the growing pipeline of biologics, biosimilars, vaccines,
3 Value Stocks We Keep Off Our Radar
Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-02 | Hider Andrew P. | -54,276 | $25.7 | $1,394,893 |
| 2026-09-02 | Foster Julie | -2,098 | $25.7 | $53,919 |
| 2026-09-01 | Teaff James | -750 | $25.48 | $19,110 |
| 2026-06-02 | Wallace Steven P. | -153 | $18.68 | $2,858 |
| 2026-06-02 | Teaff James | -321 | $18.68 | $5,996 |
| 2026-06-01 | Zielinski Anita A | +13,426 | - | - |
| 2026-05-05 | Wilkes David S. | +12,836 | - | - |
| 2026-05-05 | Wendell Amy McBride | +12,836 | - | - |
| 2026-05-05 | Shafer David Brent | +12,836 | - | - |
| 2026-05-05 | McDonnell Michael R. | +12,836 | - | - |
| 2026-05-05 | Craig Jeffrey A | +12,836 | - | - |
| 2026-05-05 | Ampofo William A. II | +12,836 | - | - |
| 2026-05-05 | SCHLICHTING NANCY M | +12,836 | - | - |
| 2026-05-05 | MORRISON PATRICIA | +12,836 | - | - |
| 2026-03-06 | Zielinski Anita A | -1,932 | $17.69 | $34,177 |
| 2026-03-06 | Soriano Maria Cecilia | -2,848 | $17.69 | $50,381 |
| 2026-03-06 | Rosenbloom David S. | -6,620 | $17.69 | $117,108 |
| 2026-03-06 | Rasul Reazur | -12,674 | $17.69 | $224,203 |
| 2026-03-06 | Grade Joel T. | -8,153 | $17.69 | $144,227 |
| 2026-03-02 | Rasul Reazur | -1,614 | $19.69 | $31,780 |
| 2026-03-02 | Soriano Maria Cecilia | -1,852 | $19.69 | $36,466 |
| 2026-03-02 | Rosenbloom David S. | -1,336 | $19.69 | $26,306 |
| 2026-02-27 | Hider Andrew P. | +488,506 | - | - |
| 2026-02-27 | Hider Andrew P. | +201,804 | - | - |
| 2026-02-27 | Carlisle Cynthia | +43,103 | - | - |
| 2026-02-27 | Carlisle Cynthia | +11,871 | - | - |
| 2026-02-27 | Carlisle Cynthia | +17,806 | - | - |
| 2026-02-27 | Soriano Maria Cecilia | +57,471 | - | - |
| 2026-02-27 | Soriano Maria Cecilia | +23,742 | - | - |
| 2026-02-27 | Rosenbloom David S. | +64,655 | - | - |
| 2026-02-27 | Rosenbloom David S. | +26,709 | - | - |
| 2026-02-27 | Grade Joel T. | +103,448 | - | - |
| 2026-02-27 | Grade Joel T. | +42,735 | - | - |
| 2026-02-27 | Zielinski Anita A | +30,864 | - | - |
| 2026-02-13 | McDonnell Michael R. | +1,811 | - | - |
| 2026-02-09 | Soriano Maria Cecilia | -918 | $21.73 | $19,948 |
| 2026-02-09 | Soriano Maria Cecilia | +2,273 | - | - |
| 2026-02-09 | Rosenbloom David S. | -5,225 | $21.73 | $113,539 |
| 2026-02-09 | Rosenbloom David S. | +17,055 | - | - |
| 2026-02-09 | Rasul Reazur | -5,770 | $21.73 | $125,382 |
| 2026-02-09 | Rasul Reazur | +18,951 | - | - |
| 2026-02-09 | Grade Joel T. | -9,144 | $21.73 | $198,699 |
| 2026-02-09 | Grade Joel T. | +30,504 | - | - |
| 2025-12-12 | Mason Jeanne K | -650 | $19.15 | $12,447 |
| 2025-12-01 | Grade Joel T. | -8,288 | $19.08 | $158,135 |